This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objectives of this study are: 1) To compare the ability of the three initial protease inhibitor-sparing antiretroviral regimens to suppress and maintain HIV-1 RNA <200 copies/mL. 2) To determine the safety and tolerability of the three initial protease inhibitor-sparing regimens.
Showing the most recent 10 out of 381 publications